These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10908092)

  • 1. Adrenergic overload and apoptosis in heart failure: implications for therapy.
    Colucci WS; Sawyer DB; Singh K; Communal C
    J Card Fail; 2000 Jun; 6(2 Suppl 1):1-7. PubMed ID: 10908092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The control of cardiomyocyte apoptosis via the beta-adrenergic signaling pathways.
    Communal C; Colucci WS
    Arch Mal Coeur Vaiss; 2005 Mar; 98(3):236-41. PubMed ID: 15816327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts.
    Xiao RP; Zhang SJ; Chakir K; Avdonin P; Zhu W; Bond RA; Balke CW; Lakatta EG; Cheng H
    Circulation; 2003 Sep; 108(13):1633-9. PubMed ID: 12975249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of beta3-adrenoreceptors agonist on beta3-adrenoreceptors expression and myocyte apoptosis in a rat model of heart failure].
    Kong YH; Li WM; Tian Y
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Mar; 16(3):142-7. PubMed ID: 15009959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small heat-shock protein Hsp20 attenuates beta-agonist-mediated cardiac remodeling through apoptosis signal-regulating kinase 1.
    Fan GC; Yuan Q; Song G; Wang Y; Chen G; Qian J; Zhou X; Lee YJ; Ashraf M; Kranias EG
    Circ Res; 2006 Nov; 99(11):1233-42. PubMed ID: 17068291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cellular and physiologic effects of beta blockers in heart failure.
    Sabbah HN
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effects of combined beta(1) adrenergic receptor antagonist and beta(2) adrenergic receptor agonist therapy on cardiac function and myocardial apoptosis in heart failure rats].
    Li WM; Gan RT; Wang X; Wu S; Shen JX; Xiu CH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):615-9. PubMed ID: 17961425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the beta2-agonist clenbuterol help to maintain myocardial potential to recover during mechanical unloading?
    Tsuneyoshi H; Oriyanhan W; Kanemitsu H; Shiina R; Nishina T; Matsuoka S; Ikeda T; Komeda M
    Circulation; 2005 Aug; 112(9 Suppl):I51-6. PubMed ID: 16159865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenergic pathways and left ventricular remodeling.
    Dorn GW
    J Card Fail; 2002 Dec; 8(6 Suppl):S370-3. PubMed ID: 12555147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure.
    Port JD; Bristow MR
    J Mol Cell Cardiol; 2001 May; 33(5):887-905. PubMed ID: 11343413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice.
    Bisognano JD; Weinberger HD; Bohlmeyer TJ; Pende A; Raynolds MV; Sastravaha A; Roden R; Asano K; Blaxall BC; Wu SC; Communal C; Singh K; Colucci W; Bristow MR; Port DJ
    J Mol Cell Cardiol; 2000 May; 32(5):817-30. PubMed ID: 10775486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced cardiac L-type calcium current response to beta2-adrenergic stimulation in heart failure.
    Zhang ZS; Cheng HJ; Ukai T; Tachibana H; Cheng CP
    J Pharmacol Exp Ther; 2001 Jul; 298(1):188-96. PubMed ID: 11408541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitonin gene-related peptide in vivo positive inotropy is attributable to regional sympatho-stimulation and is blunted in congestive heart failure.
    Katori T; Hoover DB; Ardell JL; Helm RH; Belardi DF; Tocchetti CG; Forfia PR; Kass DA; Paolocci N
    Circ Res; 2005 Feb; 96(2):234-43. PubMed ID: 15591228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system.
    Sethi R; Shao Q; Ren B; Saini HK; Takeda N; Dhalla NS
    Mol Cell Biochem; 2004 Aug; 263(1-2):11-20. PubMed ID: 15524163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct actions of intermittent and sustained β-adrenoceptor stimulation on cardiac remodeling.
    Ma X; Song Y; Chen C; Fu Y; Shen Q; Li Z; Zhang Y
    Sci China Life Sci; 2011 Jun; 54(6):493-501. PubMed ID: 21706409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cardiac beta1- and beta2-adrenoceptor stimulation in heart failure.
    Khamssi M; Brodde OE
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S133-7. PubMed ID: 11527117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of iNOS protects the aging heart against beta-adrenergic receptor stimulation-induced cardiac dysfunction and myocardial ischemic injury.
    Li D; Qu Y; Tao L; Liu H; Hu A; Gao F; Sharifi-Azad S; Grunwald Z; Ma XL; Sun JZ
    J Surg Res; 2006 Mar; 131(1):64-72. PubMed ID: 16154595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation.
    Tomita H; Nazmy M; Kajimoto K; Yehia G; Molina CA; Sadoshima J
    Circ Res; 2003 Jul; 93(1):12-22. PubMed ID: 12791704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced inhibition of L-type Ca2+ current by beta3-adrenergic stimulation in failing rat heart.
    Zhang ZS; Cheng HJ; Onishi K; Ohte N; Wannenburg T; Cheng CP
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1203-11. PubMed ID: 16135702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta(2)-Adrenergic stimulation attenuates left ventricular remodeling, decreases apoptosis, and improves calcium homeostasis in a rodent model of ischemic cardiomyopathy.
    Xydas S; Kherani AR; Chang JS; Klotz S; Hay I; Mutrie CJ; Moss GW; Gu A; Schulman AR; Gao D; Hu D; Wu EX; Wei C; Oz MC; Wang J
    J Pharmacol Exp Ther; 2006 May; 317(2):553-61. PubMed ID: 16421285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.